Beranda › Mieloma Multipel › New Jersey › Clifton
Uji klinis Mieloma Multipel di Clifton, NJ
14 studi untuk Mieloma Multipel mencari peserta di lokasi sekitar Clifton (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Menerima pesertaFase 1/2
- Hackensack University Medical Center, Hackensack · 7 mi jauhnya
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Menerima pesertaFase 4
- Hackensack University Medical Center, Hackensack · 7 mi jauhnya
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma
Menerima pesertaFase 1
- Hackensack Meridian Health - John Theurer Cancer Center, Hackensack · 7 mi jauhnya
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
Menerima pesertaFase 2
- John Theurer Cancer Center, Hackensack · 7 mi jauhnya
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Menerima pesertaFase 3
- Hackensack Meridian Health, Hackensack · 7 mi jauhnya
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
Menerima pesertaFase 1/2
- Hackensack University Medical Center, Hackensack · 7 mi jauhnya
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Menerima pesertaFase 1
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack · 7 mi jauhnya
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 1/2
- Research Site, Hackensack · 7 mi jauhnya
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Menerima pesertaFase 1
- Hackensack University Medical Center, Hackensack · 7 mi jauhnya
Mosaic Trial for Stem Cell Transplant Recipients
Menerima peserta
- Hackensack Meridian Health, Nutley · 3 mi jauhnya
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Menerima pesertaFase 1
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi jauhnya
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Menerima pesertaFase 3
- GSK Investigational Site, Hackensack · 7 mi jauhnya
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
Menerima pesertaFase 1
- Hackensack Meridian John Theurer Cancer Center, Hackensack · 7 mi jauhnya
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 1/2
- John Theurer Cancer Center at Hackensack UMC, Hackensack · 7 mi jauhnya
Uji klinis Mieloma Multipel di kota lain
- New York City, NY60 studi
- Boston, MA42 studi
- Atlanta, GA41 studi
- Houston, TX38 studi
- Durham, NC37 studi
- Nashville, TN32 studi
- Denver, CO27 studi
- Rochester, MN24 studi
- St. Louis, MO24 studi
- Columbus, OH24 studi
- Baldwin Park, CA23 studi
- Chicago, IL22 studi
Studi lain di Clifton
- Kanker Paru Non-Sel Kecil24 studi
- Kanker (semua jenis)15 studi
- Kanker Metastatik12 studi
- Leukemia Mieloid Akut12 studi
- Kanker Prostat12 studi
- Kanker Payudara12 studi
- Kanker Ovarium11 studi
- Kanker Paru10 studi
- Kanker Endometrium8 studi
- Kanker Payudara Triple-Negatif8 studi
- Kanker Kolorektal8 studi
- Karsinoma Sel Skuamosa Kepala dan Leher8 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.